(Press-News.org) Forget gears and motors. The next generation of robots may run on living muscle. Scientists are now fusing biological tissue with engineered structures to create "biohybrid robots"—machines that flex, contract, and move using the same power source we do: cells.
The potential could be striking. Imagine tiny robots swimming through your bloodstream to deliver drugs, engineered tissues that help heal damaged organs, or living systems that model diseases more faithfully than any computer. But so far, most of these robots are fragile lab prototypes, more science experiment than practical tool.
A new review in the International Journal of Extreme Manufacturing maps out how to get there. Led by Dr. Su Ryon Shin of Harvard Medical School, the study highlights how advanced fabrication methods—such as 3D bioprinting, electrospinning, microfluidics, and self-assembly—are redefining what's possible for muscle-powered robotics.
"Fabrication isn't just about building the parts. It's the key to performance," Dr. Shin explains. "The way we grow and guide muscle cells determines whether these robots can move, adapt, and last."
Muscles Meet Machines
Researchers are working with two kinds of tissue. Skeletal muscle, which contracts strongly when stimulated, offers the ability to generate powerful movement; while cardiac muscle, which beats rhythmically on its own, provides continuous and coordinated motion.
Each offers unique advantages but only if fabrication techniques are tailored to their needs. 3D bioprinting, electrospinning, microfluidics, and self-assembly all give scientists new ways to position, align, and nurture cells so they integrate with engineered frameworks. Done right, the muscle contracts in unison, transforming a patch of living tissue into a controllable robotic actuator.
The Fragility Problem
Right now, most biohybrid robots don't last long. They're tiny, delicate, and only survive under carefully managed conditions. Scaling them up or getting them to function in the messy and unpredictable world remains a huge challenge.
To fix that, researchers are experimenting with three strategies: multi-material printing to add strength and complexity; perfusable scaffolds that keep cells alive by feeding them nutrients; and modular designs that make robots tougher and more adaptable.
All these advances could eventually allow biohybrid machines to live longer, work harder, and move into medicine or even industry.
The Big Picture
The implications extend far beyond robotics. If these technical hurdles can be overcome, biohybrid systems could inaugurate a new class of machines that blur the distinction between living and engineered. A robot that flexes like a muscle can adapt, heal, and interact with the body in ways metal and plastic never could.
Shin and her colleagues believe the field is on the cusp of this transition. "The next generation of biohybrid robots will not only achieve precise actuation and adaptability," she says. "They'll overcome barriers of scale and integration. They'll actively support human health."
If fabrication technologies keep advancing, the robots of tomorrow may not clank, whir, or buzz. They may beat, contract, and grow—just like us.
International Journal of Extreme Manufacturing (IJEM, IF: 21.3) is dedicated to publishing the best advanced manufacturing research with extreme dimensions to address both the fundamental scientific challenges and significant engineering needs.
Maintain #1 in Engineering, Manufacturing for consecutive years
Average time to First Decision after Peer Review: 34 days
Open Access Publishing with APC Waivers
Visit our webpage, like us on Facebook, and follow us on Twitter and LinkedIn.
END
Robots that flex like US: The rise of muscle-powered machines
2025-10-23
ELSE PRESS RELEASES FROM THIS DATE:
Obesity: A discovery shakes 60 years of certainty about fat metabolism
2025-10-23
Our fat cells, called adipocytes, do more than just store extra weight. They play a key role in managing the body’s energy. Adipocytes accumulate fat in the form of lipid droplets that the body can use when needed—for example, during fasting periods between meals. To do this, the body uses the HSL protein like a kind of switch. When energy is lacking, HSL is activated by hormones such as adrenaline and releases fat to fuel various organs.
In the absence of HSL, one might assume that the energy tap is shut off and that fat would inevitably accumulate. Paradoxically, however, studies in mice and in patients with mutations in the HSL gene show that this does ...
Guidelines for treating hereditary hearing loss with gene therapy from international experts
2025-10-23
Up to 60% of congenital and early-onset hearing loss is caused by genetic mutations in an inherited gene, and gene therapy has recently emerged as a potential treatment option. To provide a standardized framework for conducting safe, high-quality clinical trials, a group of international experts has put together guidelines on the administration of gene therapy for hereditary hearing loss. Publishing in the Cell Press journal Med on October 23, the guidelines highlight the need for patient-centered care and respect for the diversity of perspectives within the hearing loss community.
“Cochlear gene therapy ...
Chemistry: The key to civet coffee is in the chemistry
2025-10-23
Coffee beans harvested from the faeces of the Asian palm civet (Paradoxurus hermaphroditus) may have higher levels of fats and other key flavour-enhancing compounds than traditionally harvested beans. The results, published in Scientific Reports, may help explain why this type of coffee is so prized.
Civet coffee, also known as kopi luwak, is one of the most expensive types of coffee in the world, and can sell for more than US $1,000 per kilogram of beans. The beans are harvested from the faecal matter of civets — usually Asian palm civets ...
Glucagon-like peptide-1 receptor agonists and age-related macular degeneration
2025-10-23
About The Study: In this cohort study, glucagon-like peptide-1 receptor agonist (GLP-1RA) use was associated with reduced risk of developing nonexudative age-related macular degeneration (AMD) but was not associated with progression to exudative AMD among individuals with nonexudative AMD. These findings may inform future randomized trials evaluating the ocular effects of GLP-1RAs in nondiabetic populations.
Corresponding Author: To contact the corresponding author, Benjamin K. Young, MD, MS, email youngbe@ohsu.edu.
To access ...
Prenatal exposure to fine particulate matter components and autism risk in childhood
2025-10-23
About The Study: In this large cohort study, prenatal exposure to specific fine particulate matter (PM2.5) components and postnatal ozone (O3) exposure were associated with autism spectrum disorder risk. The second and third trimesters may represent sensitive exposure windows. These findings support further research on air pollution’s role in autism spectrum disorder etiology.
Corresponding Author: To contact the corresponding author, Eric Lavigne, PhD, email eric.lavigne@hc-sc.gc.ca.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.38882)
Editor’s ...
Light exposure at night and cardiovascular disease incidence
2025-10-23
About The Study: In this cohort study, night light exposure was a significant risk factor for developing cardiovascular diseases among adults older than 40 years. These findings suggest that, in addition to current preventive measures, avoiding light at night may be a useful strategy for reducing risks of cardiovascular diseases.
Corresponding Author: To contact the corresponding author, Daniel P. Windred, PhD, email daniel.windred@flinders.edu.au.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.39031)
Editor’s ...
Shining a light on heart disease risk
2025-10-23
A new study led by Flinders University has found that being exposed to bright light at night can significantly increase the chances of developing serious heart problems, including heart attacks, strokes and heart failure.
Published in JAMA Network Open, the research is the largest study of its kind to explore how personal light exposure affects heart health using data from nearly 89,000 people in the UK.
Using wrist-worn sensors, researchers from FHMRI Sleep Health tracked over 13 million hours of light exposure and followed participants for up to 9.5 years.
The study found that people who were exposed to the brightest light at night were much more likely to develop ...
PAI-1 deficiency protects aging female mice from muscle and bone loss
2025-10-23
“These results indicate that PAI-1 is partly involved in aging-related sarcopenia and osteopenia in female mice, although the corresponding mechanisms remain unknown.”
BUFFALO, NY — October 23, 2025 — A new research paper was published in Volume 17, Issue 9 of Aging-US on September 11, 2025, titled “Roles of plasminogen activator inhibitor-1 in aging-related muscle and bone loss in mice.”
In this study led by first author Takashi Ohira and corresponding author Hiroshi Kaji from Kindai University Faculty of Medicine, researchers found that female mice lacking the gene for plasminogen ...
Snake bites: How they do it
2025-10-23
Few actions in nature inspire more fear and fascination than snake bites. And the venomous reptiles have to move fast to sink their fangs into their prey before their victim flinches, which may be as little as 60 ms when hunting rodents. Until recently, video technology was not sufficiently sophisticated to capture the deathly manoeuvres in high definition, but recent improvements have made this possible, so Alistair Evans and Silke Cleuren from Monash University, Australia, decided to get to the heart of how venomous viper, ...
New antibody restricts the growth of aggressive and treatment-resistant breast cancers
2025-10-23
A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists.
The King’s College London discovery, published today, could provide new treatment options for some of the most aggressive forms of breast cancer. This may be particularly important for patients whose cancers no longer respond to existing therapies, as well as those with triple-negative breast cancer – a subtype which lacks the receptors which are common drug targets, where treatment choices remain very limited.
The team designed an antibody that not only attacks the tumour cells directly, but also harnesses the body’s own immune ...